Cue Biopharma (CUE) shares slumped nearly 31% even after the company said a phase 2 trial of CUE-221 met its primary endpoint in certain patients with moderate-to-severe chronic spontaneous urticaria in China.

Almost 2.67 million shares of the company traded intraday, compared with a daily average of about 170,000.

Lument Finance Trust's (LFT) board suspended its quarterly dividend that would have otherwise been paid in October, it said late Friday.

Shares dropped more than 12% as intraday trading volume climbed to almost 79,000 from a daily average of over 28,000.

BofA Securities adjusted the share price target for United Parcel Service (UPS) to $108 from $115 while maintaining a neutral rating.

Shares traded 4.3% lower intraday, with trading volume at nearly 5.83 million from a daily average of about 4.72 million.

Price: 25.82, Change: -11.23, Percent Change: -30.31